论文部分内容阅读
血液制品生产中，消除或灭活乙型肝炎病毒（HBV）的重要性和措施，大约在］0年前已被一些生产企业所认识并逐步掌握。七十年代中期，病毒学家提出了“非甲非乙型肝炎病毒”（NANBHV）的问题。随着分子生物学技术的发展，1989年，确认了非甲非乙型肝炎病毒为丙型肝炎病毒（HCV）
The importance and measures to eliminate or inactivate Hepatitis B virus (HBV) in the production of blood products have been recognized and gradually mastered by some manufacturing enterprises about 0 years ago. In the mid-1970s, virologists raised the issue of “non-A non-Hepatitis B virus” (NANBHV). With the development of molecular biology technology, in 1989, it was confirmed that non-A, non-B hepatitis virus is hepatitis C virus (HCV)